A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)Xingsheng Hu, Yan Sun, Aiqin Gu et al.|Lung Cancer|2014Cited by 51
Proteomic profiling reveals the significance of lipid metabolism in small cell lung cancer recurrence and metastasisHaohua Zhu, Xingsheng Hu|Journal of Translational Medicine|2024Cited by 4